Bio

AHPRA Specialist Registration | MED0001045993 

Associate Professor Sydney Ch’ng was named one of the 100 Westpac and Australian Financial Review Women of Influence in Australia 2015.

Dr Sydney Ch’ng is a fully qualified Plastic, Reconstructive and Cosmetic Surgeon and leading surgical researcher. She is one of a few surgeons fully trained in both Plastic Surgery and Head and Neck Surgery. Her current work includes cancer surgery (head and neck cancer, melanoma and non-melanoma skin cancers), reconstructive surgery, cosmetic surgery, and academic work as Associate Professor of Surgery at the University of Sydney.

Dr Sydney Ch’ng studied medicine at the University of Melbourne. During her surgical training, she participated in the Surgeon Scientist Program through the Royal Australasian College of Surgeons (RACS). She performed two years of full time research into the biology of skin cancers, publishing many scientific papers, and presenting her research at both national and international conferences. Dr Ch’ng won a number of awards including the Young Investigator Award presented by the Australian and New Zealand Head and Neck Cancer Society (ANZHNCS), Best Proffered Paper at the ANZHNCS Annual Scientific Meeting (ASM), the Louis Barnett Prize for Best Free Paper at the RACS (NZ) ASM, and Best Scientific Poster at the RACS Annual Scientific Congress. This research culminated in the awarding of a PhD, and resulted in changes to global guidelines for the management of skin cancers.

Following this, Dr Ch’ng completed training in Plastic and Reconstructive Surgery, obtaining Fellowship of the Royal Australasian College of Surgeons (FRACS).

She undertook further training in head and neck surgery at the Sydney Head and Neck Cancer Institute and Royal Prince Alfred Hospital. This allowed her to gain extensive experience in both resection and reconstructive surgery for all types of head and neck benign and malignant (cancer) pathology.

Dr Ch’ng then completed a fellowship specialising in Adult Craniomaxillofacial (Facial Trauma and Facial Cosmetic) Surgery at the renowned Chang Gung Memorial Hospital in Taiwan, working with world leaders in this field.

Subsequently, Dr Ch’ng went to the premier cancer hospital in USA, The University of Texas MD Anderson Cancer Center in Houston, as an international fellow on the highly competitive American Society of Reconstructive Microsurgery Program. There she learnt the latest techniques in cancer surgery such as advanced microsurgery, robotic surgery, and lymphoedema surgery.

Dr Ch’ng’s practice is based at Royal Prince Alfred (RPA) Hospital, the Chris O’Brien Lifehouse, Concord Repatriation General Hospital, the Melanoma Institute of Australia, and the Mater Hospital. She collaborates with experts in medical oncology, radiation oncology, pathology, and allied health when caring for head and neck cancer and melanoma patients. Her interests include facial skin cancers (especially those involving the ear, nose, eyelids and lips), advanced skin cancers requiring complex reconstruction following resection with a focus on obtaining the best cosmetic outcome and restoring function, surgery for parotid tumours (including nerve integrity monitoring and mini-facelift incisions), facelift, neck lift and blepharoplasty (eyelid surgery).

In addition to her clinical work, Dr Ch’ng is Associate Professor of Surgery at the Institute of Academic Surgery, University of Sydney. She is the Research Lead for Plastic Surgery at RPA. She has authored numerous scientific papers and book chapters, and been awarded a number of successful research grant applications. She is an examiner for the Royal Australasian College of Surgeons, and a reviewer for highly regarded scientific journals. In 2015, she was recognised with a significant research honour at the Sydney Local Health District Innovation and Research Symposium.

She is actively involved in the supervision and training of local and overseas surgeons, trainees, and medical students. In 2016, Dr Ch’ng convened the 17th International Course on Perforator Flaps. She is the Plastic Surgery Section Convenor for the 2018 RACS Annual Scientific Conference.

Dr Ch’ng is married to a Kiwi transplant anaesthetist, and they have a daughter and a son. In her free time, she enjoys spending time with her family, travelling and reading.

Professional Affiliations

  • Australian Society of Plastic Surgeons (ASPS)
  • Australian and New Zealand Head and Heck Cancer Society (ANZHNCS)
  • Melanoma Institute of Australia (MIA)
  • Australia and New Zealand Melanoma Trial Group (ANZMTG)
  • AO CMF (Craniomaxillofacial) International
  • Sydney Facial Nerve Service

Publications:

Read more

Peer-Reviewed Publications

  1. Hurrell MJL, Heller GZ, Elliott MS, Gao K, Ebrahimi A, Clark JR, Shannon K, Palme CE, Wykes J, Gupta R, Ch’ng S, Nguyen KM, Low TH. ASO Visual Abstract: Recursive Partitioning to Determine Order of Significance of Regional Metastasis Characteristics in Head and Neck Cutaneous Squamous Cell Carcinoma. Ann Surg Oncol. 2022 Oct;29(11):7000-7001. doi:10.1245/s10434-022-12061-7. PMID: 35907993.
  2. Yung AE, Crouch G, Varey AHR, Lo S, Elliott M, Lee J, Rawson R, Gupta R, Hong A, Clark JR, Ch’ng S. Benchmarking survival outcomes following surgical management of pT3 and pT4 cutaneous squamous cell carcinoma of the head and neck. Ann Surg Oncol. 2022 Apr 13;29(8):5124-38. doi: 10.1245/s10434-022-11669-z. PMID: 35419758.
  3. Yung AE, Ch’ng S. ASO Author Reflections: Surgery for pT3 and pT4 cutaneous squamous cell carcinomas of the head and neck provides robust outcomes against which emerging treatment modalities should be compared to determine their role in the standard of care. Ann Surg Oncol. 2022 Aug;29(8):5139-5140. doi: 10.1245/s10434-022-11696-w. PMID: 35391612.
  4. Li AT, Yip JM, Choksi H, London K, Potter AJ, Lo SN, Saw RPM, Shannon KF, da Silva IP, Varey AHR, Menzies AM, Long GV, Shivalingam B, Scolyer RA, Thompson JF, Ch’ng S. Lack of association between anatomical sites of scalp melanomas and brain metastases does not support direct vascular spread. Melanoma Res. 2022 May 13. doi: 10.1097/CMR.0000000000000827. Online ahead of print. PMID: 35579680.
  5. Yung AE, Wong G, Pillinger N, Wykes J, Haddad R, McInnes S, Palme CE, Clark JR, Sanders R, Ch’ng S. Validation of a risk prediction calculator in Australian patients undergoing head and neck microsurgery reconstruction. J Plast Reconstr Aesthet Surg. 2022 Sep;75(9):3323-3329. doi: 10.1016/j.bjps.2022.04.073. PMID: 35768291
  6. Phung D, Ahmadi N, Gupta R, Clark JR, Wykes J, Ch’ng S, Elliott MS, Palme C, Shannon K, Wu R, Lee J, Low THH. Survival outcomes of perineural spread in head and neck cutaneous squamous cell carcinoma. ANZ J Surg. 2022 Sep;92(9):2299-2304. doi: 10.1111/ans.17908. PMID: 35866314
  7. Thind AS, Ashford B, Strbenac D, Mitchell J, Lee J, Mueller SA, Minaei E, Perry JR, Ch’ng S, Iyer NG, Clark JR, Gupta R, Ranson M. Whole genome analysis reveals the genomic complexity in metastatic cutaneous squamous cell carcinoma. Front Oncol. 2022 Aug 02;12:919118. doi:10.3389/fonc.2022.919118. PMID: 35982973.
  8. Lawless AK, Coker DJ, Lo SN, Ahmed T, Scolyer RA, Ch’ng S, Nieweg OE, Shannon K, Spillane A, Stretch JR, Thompson JF, Saw RPM. Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma Metastases. Ann Surg Oncol. 2022 Jun 30. doi: 10.1245/s10434-022-11997-0. Online ahead of print. PMID: 35771368.
  9. van Akkooi ACJ, Hieken TJ, Burton EM, Ariyan C, Ascierto PA, Asero SVMA, Blank CU, Block MS, Boland GM, Caraco C, Ch’ng S, Davidson BS, Neto JPD, Faries MB, Gershenwald JE, Grunhagen DJ, Gyorki DE, Han D, Hayes AJ, van Houdt WJ, Karakousis GC, Klop WMC, Long GV, Lowe MC, Menzies AM, Bagge RO, Pennington TE, Rutkowski P, Saw RPM, Scolyer RA, Shannon K, Sondak VK, Tawbi H, Testori AAE, Tetzlaff M, Thompson JF, Zager JS, Zuur CL, Wargo JA, Spillane AJ, Ross MI, International Neoadjuvant Melanoma Consortium (INMC). Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC). Ann Surg Oncol. 2022 Aug;29(8):5241-5242. doi: 10.1245/s10434-022-11622-0. PMID: 35426590.
  10. Hayler R, Sudirman SR, Clark J, Shannon K, Elliott M, Palme CE, Wykes J, Ch’ng S, Low TH. Oral Cavity Reconstruction over a 30-Year Period at a Dedicated Tertiary Head and Neck Cancer Centre. Indian Journal of Surgery. 2022 Feb 10. doi:10.1007/s12262-022-03336-0.
  11. Reijers IL, Rawson RV, Colebatch AJ, Rozeman EA, Menzies AM, van Akkooi ACJ, Shannon KF, Wouters MW, Saw RPM, van Houdt WJ, Zuur CL, Nieweg OE, Ch’ng S, Klop WMC, Spillane AJ, Long GV, Scolyer RA, van de Wiel BA, Blank CU. Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma. JAMA Surg. 2022 Apr 1;157(4):335-342. doi: 10.1001/jamasurg.2021.7554. PMID: 35138335.
  12. van Akkooi ACJ, Hieken TJ, Burton EM, Ariyan C, Ascierto PA, Asero SVMA, Blank CU, Block MS, Boland GM, Caraco C, Ch’ng S, Davidson BS, Neto JPD, Faries MB, Gershenwald JE, Grunhagen DJ, Gyorki DE, Han D, Hayes AJ, van Houdt WJ, Karakousis GC, Klop WMC, Long GV, Lowe MC, Menzies AM, Bagge RO, Pennington TE, Rutkowski P, Saw RPM, Scolyer RA, Shannon K, Sondak VK, Tawbi H, Testori AAE, Tetzlaff M, Thompson JF, Zager JS, Zuur CL, Wargo JA, Spillane AJ, Ross MI, International Neoadjuvant Melanoma Consortium (INMC). Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC). Ann Surg Oncol. 2022 Jun;29(6)3694-3708. doi: 10.1245/s10434-021-11236-y. PMID: 35089452.
  13. Hurrell MJ, Heller GZ, Elliott MS, Gao K, Ebrahimi A, Clark JR, Shannon KF, Palme CE, Wykes J, Gupta R, Ch’ng S, Nguyen K, Low THH. Recursive Partitioning to Determine Order of Significance of Regional Metastasis Characteristics in Head and Neck Cutaneous Squamous Cell Carcinoma. Ann Surg Oncol. 2022 May 15. doi: 10.1245/s10434-022-11863-z. Online ahead of print. PMID: 35569073.
  14. Reijers ILM, Menzies AM, van Akkooi ACJ, Versluis JM, van den Heuvel NMJ, Saw RPM, Pennington TE, Kapiteijn E, van der Veldt AAM, Suijkerbuijk KPM, Hospers GAP, Rozeman EA, Klop WMC, van Houdt WJ, Sikorska K, van der Hage JA, Grünhagen DJ, Wouters MW, Witkamp AJ, Zuur CL, Lijnsvelt JM, Acosta AT, Grijpink-Ongering LG, Gonzalez M, Jóźwiak K, Bierman C, Shannon KF, Ch’ng S, Colebatch AJ, Spillane AJ, Haanen JBAG, Rawson RV, van de Wiel BA, van de Poll-Franse LV, Scolyer RA, Boekhout AH, Long GV. Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial. Nat Med. 2022 Jun 5;28(6):1178-1188. doi.org/10.1038/s41591-022-01851-x.
  15. Potter AJ, Colebatch AJ, Rawson RV, Ferguson PM, Cooper WA, Gupta R, O’Toole S, Saw RPM, Ch’ng S, Menzies AM, Long GV, Scolyer RA. Pathologist initiated reflex BRAF mutation testing in metastatic melanoma: experience at a specialist melanoma treatment centre. Pathol. 2022 Mar 3;54(5):526-532. doi: 10.1016/j.pathol.2021.12.290. PMID: 35249747.
  16. Scolyer RA, Atkinson V, Gyorki DE, Lambie D, O’Toole S, Saw RPM, Amanuel B, Angel CM, Button-Sloan AE, Carlino MS, Ch’ng S, Colebatch AJ, Daneshvar D, da Silva IP, Dawson T, Ferguson PM, Foster-Smith E, Fox SB, Gill AJ, Gupta R, Henderson MA, Hong AM, Howle JR, Jackett LA, James C, Lee CS, Lochhead A, Loh D, McArthur GA, McLean CA, Menzies AM, Nieweg OE, O’Brien BH, Pennington TE, Potter AJ, Prakash S, Rawson RV, Read RL, Rtshiladze MA, Shannon KF, Smithers BM, Spillane AJ, Stretch JR, Thompson JF, Tucker P, Varey AHR, Vilain RE, Wood BA, Long GV. BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting. Pathol. 2022 Feb 1;54(1):6-19. doi.org/10.1016/j.pathol.2021.11.002. Epub 2021 Dec 20. PMID: 34937664.
  17. Irawati N, Moghadam A, Abdul-Razak M, Strach M, Elliott M, Ch’ng S, Shannon KF, Palme CE, Clark JR, Wykes J, Low THH. Outcomes after definitive treatment for head and neck angiosarcoma. ANZ J Surg;2022 Jun;92(6)1407-1414. doi.org/10.1111/ans.17695. PMID: 35531880
  18. El Sharouni M, Scolyer RA, van Gils CH, Ch’ng S, Nieweg OE, Pennington TE, Saw RPM, Shannon K, Spillane A, Stretch J, Witkamp AJ, Sigurdsson V, Thompson JF, van Diest PJ, Lo SN. Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomes. Eur J Cancer. 2022 May;167:123-132. doi: 10.1016/j.ejca.2021.12.035. Epub 2022 Mar 5. PMID: 35256245.
  19. El Sharouni M, Scolyer RA, van Gils CH, Ch’ng S, Nieweg OE, Pennington TE, Saw RPM, Shannon K, Spillane A, Stretch J, Witkamp AJ, Sigurdsson V, Thompson JF, van Diest PJ, Lo SN. Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients. Eur J Cancer. 2022 May;167:133-141. doi:10.1016/j.ejca.2021.12.036. Epub 2022 Feb 22. PMID: 35216870.
  20. Petrides GA, Dunn M, Charters E, Venchiarutti R, Cheng K, Froggatt C, Mukherjee P, Wallace C, Howes D, Leinkram D, Singh J, Nguyen K, Low THH, Ch’ng S, Wykes J, Clark JR. Health-related quality of life in maxillectomy patients undergoing dentoalveolar rehabilitation. Oral Oncol. 2022 Mar;126:105757. doi: 10.1016/j.oraloncology.2022.105757. Epub 2022 Feb 1.PMID: 35121398.
  21. Ho G, Schwartz R, Melhoranse-Gouveia B, O’Sullivan NA, Cheung VKY, Ch’ng S, Guitera P, Martin L. Utility of optical coherence tomography in basal cell naevus syndrome. Australas J Dermatol. 2022 Nov; 63(4):e331-e335. doi: 10.1111/ajd.13921. PMID: 36125195
  22. Regio Pereira A, Guitera P, Ferguson PM, Ch’ng S, Hirata S. Complex melanoma of the scalp: diagnosis and management aided by confocal microscopy. Australas J of Dermatol. 2022 Feb;63(1):105-109. doi: 10.1111/ajd.13735. Epub 2021 Oct 26.PMID: 34699066
  23. Zhou D, Bhadri V, Luk P, Ch’ng S, Franks D, Hong A. Left cheek sclerosing rhabdomyosarcoma and development of isolated free flap donor site metastasis. BMJ Case Reports CP. 2022 Apr 7;15(4): e248390. doi: 10.1136/bcr-2021-248390. PMID: 35393277
  24. Every J, Dawson R, Leinkram D, Elliott M, Ch’ng S, Low H, Palme C, Clark JR, Wykes J. Effect of operative time on complications associated with free flap reconstruction of the head and neck. Clin Otolaryngol. 2022 Mar 20. doi: 10.22541/au.164781288.88404011/v1. Online ahead of print.
  25. Ferguson AL, Sharman AR, Allen RO, Ye T, Lee JH, Low THH, Ch’ng S, Palme CE, Ashford B, Ranson M, Clark JR, Patrick E, Gupta R, Palendira U. High-dimensional and spatial analysis reveals immune landscape dependent progression in cutaneous squamous cell carcinoma. Clin Cancer Res. 2022 Nov 1. doi: 10.1158/1078-0432.CCR-22-1332. PMID: 36044477.
  26. Rozeman EA, Hoefsmit EP, Reijers ILM, Saw RPM, Versluis JM, Krijgsman O, Dimitriadis P, Sikorska K, van de Wiel BA, Eriksson H, Gonzalez M, Torres Acosta A, Grijpink-Ongering LG, Shannon K, Haanen JBAG, Stretch J, Ch’ng S, Nieweg OE, Mallo HA, Adriaansz S, Kerkhoven RM, Cornelissen S, Broeks A, Klop WMC, Zuur CL, van Houdt WJ, Peeper DS, Spillane AJ, van Akkooi ACJ, Scolyer RA, Schumacher TNM, Menzies AM, Long GV, Blank CU. Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma. Nat Med. 2021 Feb;27(2):256-263. doi: 10.1038/s41591-020-01211-7. Epub 2021 Feb 8. PMID: 33558721.
  27. Ch’ng S, Scolyer RA, Thompson JF. ASO Author Reflections: Surgical Resection May Improve the Outcome for Patients with Residual Metastatic Melanoma When Modern Systemic Therapies Have Not Achieved Complete Disease Control. Ann Surg Oncol. 2021 Oct;28(11):6124-6125. doi: 10.1245/s10434-021-10514-z. Epub 2021 Aug 9. PMID: 34373967.
  28. Li AT, Vakharia K, Lo SN, Varey AHR, Carlino MS, Saw RPM, Shannon KF, Howle JR, Pennington TE, Stretch JR, Nieweg OE, Spillane AJ, Long GV, Menzies AM, Scolyer RA, Thompson JF, Ch’ng S. Survival outcomes of salvage metastasectomy after failure of modern-era systemic therapy for melanoma. Ann Surg Oncol. 2021 Oct;28(11):6109-6123. doi: 10.1245/s10434-021-10489-x. Epub 2021 Aug 4. PMID: 34347220.
  29. Ch’ng S, Uyulmaz S, Carlino MS, Pennington TE, Shannon KF, Rtshiladze M, Stretch JR, Nieweg OE, Varey AHR, Hsiao E, Kapoor R, da Silva IP, Lo SN, Spillane AJ, Scolyer RA, Long GV, Hong AM, Saw RPM, Thompson JF, Menzies AM. Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies. Eur J Can. 2021 August; 153:8-15. doi: 10.1016/j.ejca.2021.04.037. Epub 2021 Jun 12. PMID: 34126335.
  30. Aivazian K, Ahmed T, El Sharouni MA, Stretch JR, Saw RPM, Spillane AJ, Shannon KF, Ch’ng S, Nieweg OE, Thompson JF, Lo N, Scolyer RA. Histological regression in melanoma: impact on sentinel lymph node status and survival. Mod Pathol. 2021 Nov;34(11):1999-2008. doi: 10.1038/s41379-021-00870-2. Epub 2021 Jul 10. PMID: 34247192.
  31. Aivazian K, Ahmed T, El Sharouni MA, Stretch JR, Saw RPM, Spillane AJ, Shannon KF, Ch’ng S, Nieweg OE, Thompson JF, Lo N, Scolyer RA. Correction to: Histological regression in melanoma: impact on sentinel lymph node status and survival. Mod Pathol. 2021 Nov;34(11):2091. doi: 10.1038/s41379-021-00878-8. PMID: 34349230.
  32. Versluis JM, Reijers ILM, Rozeman EA, Menzies AM, van Akkooi ACJ, Wouters MW, Ch’ng S, Saw RPM, Scolyer RA, van de Wiel BA, Schilling B, Long GV, Blank CU. Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma. Eur J Can. 2021 May;148:51-57. doi: 10.1016/j.ejca.2021.02.012. Epub 2021 Mar 15. PMID: 33735809.
  33. Braden J, Potter AJ, Paver E, Menzies AM, Carlino MS, Au-Yeung C, Saw RPM, Spillane AJ, Stretch JR, Shannon KF, Pennington TE, Ch’ng S, Gyorki D, Howle J, Deneshvar D, Silva IP, Scolyer RA, Wilmott JS, Long GV. NeoTrio trial: Optimal neoadjuvant sequencing of anti-PD1 and BRAF targeting therapy in resectable BRAF mutant stage IIIB/C/D melanoma: Results of translational investigations. Asia-Pacific Journal of Clinical Oncology. 2021;17:163-163.
  34. Li AT, Maw AM, Hsiao E, Ch’ng S, Long GV, Shannon KF, Morrison EJ. Bilateral facial neuritis associated with dabrafenib and trametinib after failure of neoadjuvant immunotherapy for stage III melanoma. ANZ J Surg. 2022 Jan;92(1-2):247-250. doi: 10.1111/ans.16992. Epub 2021 Jun 14. PMID: 34124833.
  35. Petrides GA, Hicks G, Dunn M, Froggatt C, Wallace C, Howes D, Leinkram D, Low THH, Ch’ng S, Wykes J, Palme CE, ClarkJR. Dentoalveolar outcomes in maxillary reconstruction: A retrospective review of 85 maxillectomy reconstructions. ANZ J Surg. 2021 Jul;91(7-8):1472-1479. doi: 10.1111/ans.17001. Epub 2021 Jun 14. PMID: 34124825.
  36. Dawson R, Phung D, Every J, Gunawardena D, Low THH, Ch’ng S, Clark JR, Wykes J, Palme CE. Tracheostomy in free‐flap reconstruction of the oral cavity: can it be avoided? A cohort study of 187 patients. ANZ J Surg. 2021 Jun;91(6):1246-1250. doi: 10.1111/ans.16762. Epub 2021 Apr 6. PMID: 33825282.
  37. Rawson RV, Adhikari C, Bierman C, Lo SN, Shklovskaya E, Rozeman EA, Menzies AM, van Akkooi ACJ, Shannon KF, Gonzalez M, Guminski AD, Tetzlaff MT, Stretch JR, Eriksson H, van Thienen JV, Wouters MW, Haanen JBAG, Klop WMC, Zuur CL, van Houdt WJ, Nieweg OE, Ch’ng S, Rizos H, Saw RPM, Spillane AJ, Wilmott JS, Blank CU, Long GV, van de Wiel BA, Scolyer RA. Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma. Ann Oncol. 2021 Jun;32(6):766-777. doi: 10.1016/j.annonc.2021.03.006. Epub 2021 Mar 17.PMID: 33744385.
  38. Crouch G, Wong GL, Hong J, Varey AHR, Haddad R, Wang ZZ, Wykes J, Koutalistras N, Clark JR, Solomon M, Bannon P, McBride KE, Ch’ng S. Validated specialty‐specific models for multi‐disciplinary microsurgery training laboratories: a systematic review. ANZ J Surg. 2021 Jun;91(6):1110-1116. doi: 10.1111/ans.16721. Epub 2021 Mar 15. PMID: 33719142.
  39. Mooney CP, Clark JR, Shannon KF, Palme CE, Ebrahimi A, Gao K, Ch’ng S, Elliott M, Gupta R, Low THH. The significance of regional metastasis location in head and neck cutaneous squamous cell carcinoma. Head Neck. 2021 Sep;43(9):2705-2711. doi: 10.1002/hed.26744. Epub 2021 May 21. PMID: 34019319.
  40. Every J, Subramaniam N, Dawson R, Ch’ng S, Low THH, Palme CE, Clark JR, Wykes J. Microvascular reconstruction of head and neck defects in the elderly. ANZ J Surg. 2021 May;91(5):969-974. doi: 10.1111/ans.16771. Epub 2021 Apr 6. PMID: 33825309.
  41. Yung A, Que MS, Lo S, Aggarwal S, Hong AM, Tin MM, Low THH, Clark JR, Gupta R, Ch’ng S. Validation of the American Joint Committee on Cancer Staging in Squamous Cell Carcinoma of the Vermilion Lip. Ann Surg Oncol. 2021 Jun;28(6):3092-3099. doi: 10.1245/s10434-020-09431-4. Epub 2021 Jan 2. PMID: 33389299.
  42. Sinclair S, Zhou K, Yip JM, Aggarwal S, Jukes A, Clark JR, Shivalingam B, Ch’ng S. Microsurgical scalp reconstruction and cranioplasty refined. Aust J Plast Surg. 2022 Mar 31;5(1):74-79. doi.org/10.34239/ajops.v5n1.292.
  43. Crouch G, Sinha S, Lo S, Saw RPM, Lee KK, Stretch J, Shannon K, Guitera P, Scolyer RA, Thompson JF, Ch’ng S. Clinical Outcomes following Surgical Treatment of Lentigo Maligna of the Head and Neck. Eur J Surg Oncol. 2021 May;47(5):1145-1151. doi: 10.1016/j.ejso.2020.09.028. Epub 2020 Sep 23. PMID: 33023795.
  44. Mooney, CP, Gao K, Clark JR, Gupta R, Shannon K, Palme CE, Ebrahimi A, Ch’ng S, Low THH. Soft Tissue Metastases in Head and Neck Cutaneous Squamous Cell Carcinoma. Laryngoscope. 2021 Apr;131(4):e1209-e1213. doi: 10.1002/lary.29064.Epub 2020 Sep 14. PMID: 32926433.
  45. Lee LP, Karagiannis P, Kim D, Thompson JF, Saw R, Lee KK, Ch’ng S. Lower Lip Reconstruction Revisited – Technical Solutions to Prevent Oral Incontinence and Maximize Vermilion Anterior Projection. Plast Reconstr Surg. 2020 Oct;146(4):515e-516e. doi: 10.1097/PRS.0000000000007194. PMID: 32649607.
  46. Lo SN, Ma J, Scolyer RA, Haydu LE, Stretch JR, Saw RPM, Nieweg OE, Shannon KF, Spillane AJ, Ch’ng S, Mann GJ, Gershenwald JE, Thompson JF, Varey AHR. An improved risk-prediction calculator for sentinel node positivity in melanoma patients: the MIA nomogram. J Clin Oncol. 2020 Aug 20;38(24):2719-2727. doi: 10.1200/JCO.19.02362. Epub 2020 Jun 12.PMID: 32530761.
  47. Holtkamp LHJ, Chakera AH, Fung S, Saw RPM, Lee KK, Ch’ng S, Gonzalez M, Thompson JF, Emmett L, Nieweg OE. Staging 18F-FDG PET/CT influences the treatment plan in melanoma patients with satellite or in-transit metastases. Melanoma Research. 2020 Aug;30(4):358-363. doi: 10.1097/CMR.0000000000000666. PMID: 32628431.
  48. Gonzalez M, Menzies A, Penington T, Saw RP, Spillane AJ, Stretch J, Ch’ng S, Nieweg OE, Rojas MC, Osorio M, Rawson RV, Ferguson PM, Rizos H, Lo S, Scolyer RA, Long GV. A phase II study of neoadjuvant pembrolizumab and lenvatinib for resectable stage III melanoma: The neopele study. Journal of Clinical Oncology. 2020 May 25;38(15_suppl):TPS10088-TPS10088. doi: 10.1200/JCO.2020.38.15_suppl.TPS10088.
  49. Hayler R, Clark J, Croxson G, Coulson S, Hussain G, Ngo Q, Ch’ng S, Low THH. Sydney Facial Nerve Clinic: Experience of A Multidisciplinary Team. ANZ J Surg. 2020 May;90(5):856-860. doi: 10.1111/ans.15782. Epub 2020 Mar 4. PMID: 32129559.
  50. Hasmat S, Mooney C, Gao K, Palme C, Ebrahimi A, Ch’ng S, Gupta R, Low THH, JR Clark. Regional Metastasis in Head and Neck Cutaneous Squamous Cell Carcinoma: An Update on the Significance of Extra-Nodal Extension and Soft Tissue Metastasis. Ann Surg Oncol. 2020 Aug;27(8):2840-2845. doi: 10.1245/s10434-020-08252-9. Epub 2020 Feb 18. PMID: 32072378.
  51. Diefenbach RJ, Lee JH, Strbenac D, Yang JYH, Menzies AM, Carlino MS, Long GV, Spillane AJ, Stretch JR, Saw RPM, Thompson JF, Ch’ng S, Scolyer RA, Kefford RF, Rizos H. Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic Melanoma. Cancers (Basel). 2019 Nov 29;11(12):1905. doi: 10.3390/cancers11121905. PMID: 31795494.
  52. Mazzola F, Smithers F, Cheng K, Mukherjee P, Low THH, Ch’ng S, Palme CE, Clark JR. Time and cost-analysis of virtual surgical planning for head and neck reconstruction: A matched pair analysis. Oral Oncol. 2020 Jan;100:104491. doi: 10.1016/j.oraloncology.2019.104491. Epub 2019 Nov 30. PMID: 31794886.
  53. Hasmat S, Low THH, Krishnan A, Coulson S, Ch’ng S, Ashford BG, Croxson G, Clark JR. Chimeric Vastus Lateralis and Anterolateral Thigh Flap for Restoring Facial Defects and Dynamic Function following Radical Parotidectomy. Plast Reconstr Surg. 2019 Nov;144(5):853e-863e. doi: 10.1097/PRS.0000000000006183. PMID: 31688764.
  54. Den Hondt M, Starr MW, Millett MC, Smyth J, Scolyer RA, Shannon KF, Thompson JF, Ch’ng S. Surgical management of the neck in patients with metastatic melanoma in parotid lymph nodes. J Surg Oncol. 2019 Dec;120(8):1462-1469. doi: 10.1002/jso.25732. PMID: 31650567.
  55. Zilberg C, Lee MW, Kraitsek S, Ashford B, Ranson M, Shannon K, Iyer NG, Ch’ng S, Low THH, Palme C, Clark J, Gupta R, Yu B. Is high-risk cutaneous squamous cell carcinoma of the head and neck a suitable candidate for current targeted therapies? J Clin Pathol. 2020 Jan;73(1):17-22. doi: 10.1136/jclinpath-2019-206038. Epub 2019 Jul 12. PMID: 31300530.
  56. Mooney CP, Martin RCW, Dirven R, Ashford BG, Shannon K, Palme CE, Ngo Q, Wykes J, Davies S, Gao K, Ch’ng S, Low THH, Gupta R, Clark JR. Sentinel node biopsy in 105 high-risk cutaneous SCCs of the head and neck: Results of a multicenter prospective study. Ann Surg Oncol. 2019 Dec;26(13):4481-4488. doi: 10.1245/s10434-019-07865-z. Epub 2019 Oct 3. PMID: 31583542.
  57. Long GV, Saw RPM, Lo S, Nieweg OE, Shannon KF, Gonzalez M, Guminski A, Lee JH, Lee H, Ferguson PM, Rawson RV, Wilmott JS, Thompson JF, Kefford RF, Ch’ng S, Stretch JR, Emmett L, Kapoor R, Rizos H, Spillane AJ, Scolyer RA, Menzies AM. Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial. Lancet Oncol. 2019 Jul;20(7):961-971. doi: 10.1016/S1470-2045(19)30331-6.Epub 2019 Jun 3. PMID: 31171444.
  58. Rozeman EA, Menzies AM, van Akkooi ACJ, Adhikari C, Bierman C, van de Wiel BA, Scolyer RA, Krijgsman O, Sikorska K, Eriksson H, Broeks A, van Thienen JV, Guminski AD, Acosta AT, Ter Meulen S, Koenen AM, Bosch LJW, Shannon K, Pronk LM, Gonzalez M, Ch’ng S, Grijpink-Ongering LG, Stretch J, Heijmink S, van Tinteren H, Haanen JBAG, Nieweg OE, Klop WMC, Zuur CL, Saw RPM, van Houdt WJ, Peeper DS, Spillane AJ, Hansson J, Schumacher TN, Long GV, Blank CU. Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial. Lancet Oncol. 2019 Jul;20(7):948-960. doi: 10.1016/S1470-2045(19)30151-2. Epub 2019 May 31. PMID: 31160251.
  59. Mueller SA, Gauthier MA, Ashford B, Gupta R, Gayevskiy V, Ch’ng S, Palme CE, Shannon K, Clark JR, Ranson M, Cowley MJ. Mutational Patterns in Metastatic Cutaneous Squamous Cell Carcinoma. J Invest Dermatol. 2019 July;139(7):1449-1458.e1. doi: 10.1016/j.jid.2019.01.008. Epub 2019 Jan 23. PMID: 30684551.
  60. Ch’ng S. PRS Global Open in the Land Down Under. Plast Reconstr Surg Glob Open. 2018 Nov 21;6(11):e1903. doi: 10.1097/GOX.0000000000001903. PMID: 30881775.
  61. Moeckelmann N, Ebrahimi A, Tou YK, Gupta R, Low THH, Ashford B, Ch’ng S, Palme CE, Clark JR. Prognostic implications of the 8th edition American Joint Committee on Cancer (AJCC) staging system in oral cavity squamous cell carcinoma. Oral Oncol. 2018 Oct;85:82-86. doi:10.1016/j.oraloncology.2018.08.013. Epub 2018 Sep 4. PMID: 30220324
  62. Ch’ng S, Neligan PC. The evolution of head and neck reconstruction. Aust J Plast Surg. 2018 Sep; 1(2):24-30. doi:10.34239/ajops.v1i2.117.
  63. Zhou KJ, Luong JK, Clark JR, Ch’ng S. Coned radial forearm free flap for Improved retention of orbital prosthesis following orbital exenteration. Plast Reconstr Surg. 2018 Nov;142(5):818e-819e. doi: 10.1097/PRS.0000000000004910. PMID: 30119127.
  64. Ch’ng S. Commentary on: Supratrochlear Artery Based Periosteal Flaps: A New Alternative Technique for Nasal Lining Reconstruction. Plast Reconstr Surg. 2018 Apr;142(1): 101e-102e. doi: 10.1097/prs.0000000000004509.
  65. Badlani J, Gupta R, Smith J, Ashford B, Ch’ng S, Veness M, Clark J. Metastases to the parotid gland – A review of the clinicopathological evolution, molecular mechanisms and management. Surg Oncol. 2018 Mar;27(1):44-53. doi: 10.1016/j.suronc.2017.11.007. Epub 2017 Dec 2. PMID: 29549903.
  66. Vasan K, Low THH, Gupta R, Ashford B, Asher R, Gao K, Ch’ng S, Palme CE, Clark JR. Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma. Head Neck. 2018 May;40(5):993-999. doi: 10.1002/hed.25066. Epub 2018 Jan 23. PMID: 29360276.
  67. Moeckelmann N, Ebrahimi A, Dirven R, Liu J, Low THH, Gupta R, Ashford B, Ch’ng S, Palme CE, Clark JR. Analysis and Comparison of the 8th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System in Cutaneous and Oral Squamous Cell Cancer of the Head and Neck. Ann Surg Oncol. 2018 Jun;25(6):1730-1736. doi: 10.1245/s10434-018-6340-x. Epub 2018 Jan 19. PMID: 29352431
  68. Liu JEbrahimi ALow THHGao KPalme CE, Ch’ng SAshford BGIyer NGClark JRGupta R. Predictive value of the 8th edition American Joint Commission Cancer (AJCC) nodal staging system for patients with cutaneous squamous cell carcinoma of the head and neck. J Surg Oncol. 2018 Mar;117(4):765-772. doi: 10.1002/jso.24883. Epub 2017 Oct 19. PMID: 29049841.
  69. Zilberg C, Lee M, Yu B, Ashford B, Kraitsek S, Ranson M, Shannon K, Cowley M, Iyer NG, Palme C, Ch’ng S, Low THH, O’Toole S, Clark J, Gupya R. Analysis of Clinically Relevant Somatic Mutations in High Risk Head and Neck Cutaneous Squamous Cell Carcinoma. Mod Pathol. 2018 Feb;31(2):275-287. doi: 10.1038/modpathol.2017.128. Epub 2017 Oct 6. PMID: 28984303.
  70. Karagiannis P, Clark JR, Ch’ng S. The Inside-Out Septal Mucoperichondrial Flap – Reconstruction of Nasal Lining Simplified. Plast Reconstr Surg. 2017 Oct;140(4):644e-645e. doi: 10.1097/PRS.0000000000003740. PMID: 28953755.
  71. Roper E, Lum T, Palme CE, Ashford B, Ch’ng S, Ranson M, Boyer M, Clark J, Gupta R.  PD-L1 expression predicts longer disease free survival in high risk head and neck cutaneous squamous cell carcinoma. Pathology. 2017 Aug;49(5):499-505. doi: 10.1016/j.pathol.2017.04.004. Epub 2017 Jun 27. PMID: 28666643.
  72. Brunner M, Ch’ng S, Shannon K, Clifford A, Ashford B, Elliott M, Clark JR. Bone resection for facial cutaneous malignancies. J Surg Oncol. 2017 Sep;116(4):545-549. doi: 10.1002/jso.24693. Epub 2017 Jun 19. PMID: 28628727.
  73. Ch’ng S, Skoracki RJ, Selber JC, Yu P, Martin JW, Hofstede TM, Chambers MS, Liu J, Hanasono MM. Osseointegrated implant based dental rehabilitation in head and neck reconstruction patients. Head Neck. 2016 Apr;38 Suppl 1:E321-7. doi: 10.1002/hed.23993. Epub 2015 Jun 29. PMID: 25546139.
  74. Low THH, Gao K, Gupta R, Clifford A, Elliott M, Ch’ng S, Milross C, Clark JR. Factors predicting poor outcomes in T1N0 oral squamous cell carcinoma: indicators for treatment intensification. ANZ J Surg. 2016 May;86(5):366-71. doi: 10.1111/ans.13504. Epub 2016 Mar 17. PMID: 26991038
  75. Heiduschka G, Virk SA, Palme CE, Ch’ng S, Elliot M, Gupta R, Clark J. Margin to tumor thickness ratio – A predictor of local recurrence and survival in oral squamous cell carcinoma. Oral Oncol. 2016 Apr;55:49-54. doi: 10.1016/j.oraloncology.2016.01.010. Epub 2016 Feb 6. PMID: 26861256.
  76. Maher NG, Collgros H, Uribe P, Ch’ng S, Rajadhyaksha M, Guitera P. In vivo confocal microscopy for the oral cavity: Current state of the field and future potential. Oral Oncol. 2016 Mar;54:28-35. doi: 10.1016/j.oraloncology.2016.01.003.Epub 2016 Jan 16.PMID: 26786962.
  77. Smith JA, Virk S, Palme CE, Low THH, Ch’ng S, Gupta R, Gao K, Clark JR. Age is not a predictor of prognosis in metastatic cutaneous squamous cell carcinoma of the head and neck. ANZ J Surg. 2018 Apr;88(4):E273-E277. doi: 10.1111/ans.13757. Epub 2016 Nov 7. PMID: 29611361.
  78. Saw R, Allan C, Barbour A, Ch’ng S, Coventry BJ, Gyorki D, Henderson M, Howle J, Hughes TM, Lee K, Neuhaus S, Saunders C, Shannon K, Smithers M, Speakman D, John Spillane, Stretch J. Sentinel node biopsy in patients with intermediate and thick melanomas – A balanced view. Aust Fam Physician. 2015 Dec;44(12):876. PMID: 27505913.
  79. Ch’ng S, Gupta R, Clark JR. Reply to margin assessment in oral squamous cell carcinoma. Cancer. 2014 Feb 1;120(3):454. doi: 10.1002/cncr.28430. Epub 2013 Nov 5. PMID: 24452677.
  80. Ch’ng S, Wong G, Clark JR. Reconstruction of the trachea. J Reconstr Microsurg. 2014 Mar;30(3):153-162. doi: 10.1055/s-0033-1358786.Epub 2013 Dec 12. PMID: 24338486.
  81. Ch’ng S, Oates J, Gao K, Foo K, Davies S, Brunner M, Clark JR. Prospective quality of life assessment between treatment groups for oral cavity squamous cell carcinoma. Head Neck. 2014 Jun;36(6):834-840. doi: 10.1002/hed.23387.Epub 2013 Sep 2.PMID: 23720248.
  82. Ch’ng S, Ashford B, Clark JR. Alignment of the double barrel fibula free flap for better cosmesis and adequate bone height for osseointegrated dental implants. Plast Reconstr Surg. 2013 Oct;132(4):688e-689e. doi: 10.1097/PRS.0b013e31829fe398. PMID: 24076735.
  83. Chen CT, Ch’ng S, Huang F, Chen YR. Management of malocclusion and facial asymmetry secondary to fractures of the mandibular condyle process. Ann Plast Surg. 2013 Dec;71 Suppl 1:S8-12. doi: 10.1097/SAP.0000000000000039. PMID: 24284746.
  84. Ch’ng S, Corbett-Burns S, Stanton N, Gao K, Shannon, K, Clifford A, Gupta R, Clark JR. Close margin alone does not warrant postoperative adjuvant radiotherapy in oral squamous cell carcinoma. Cancer. 2013 Jul 1;119(13):2427-2437. doi: 10.1002/cncr.28081. Epub 2013 Apr 10. PMID: 23576156
  85. Ch’ng S, Choi V, Elliott M, Clark JR. Relationship between postoperative complications and survival after free flap reconstruction for oral cavity squamous cell carcinoma. Head Neck. 2014 Jan;36(1):55-9. doi: 10.1002/hed.23266. Epub 2013 Apr 4.PMID: 23559547.
  86. Hasan Z, Gore SM, Ch’ng S, Ashford B, Clark J. Options for configuring the scapular free flap in maxillary, mandibular and calvarial reconstruction. Plast Reconstr Surg. 2013 Sep;132(3):645-655. doi: 10.1097/PRS.0b013e31829acf5c. PMID: 23676972.
  87. McLean T, Brunner M, Ebrahimi A, Gao K, Ch’ng S, Veness MJ, Clark JR. Concurrent primary and metastatic cutaneous head and neck squamous cell carcinoma: Analysis of prognostic factors. Head Neck. 2013 Aug;35(8):1144-8. doi: 10.1002/hed.23102. Epub 2012 Aug 21. PMID: 22907905.
  88. Ch’ng S, Clark JR, Brunner M, Palme CE, Morgan GJ, Veness MJ. Relevance of the primary lesion in the prognosis of metastatic cutaneous squamous cell carcinoma. Head Neck. 2013 Feb;35(2):190-4. doi: 10.1002/hed.22941. Epub 2012 Mar 16.PMID: 22422542.
  89. Ch’ng S, Pinna A, Ioannou K, Juszczyk K, Shannon K, Clifford A, Uren R, Clark JR. Assessment of second tier lymph nodes in melanoma and implications for extent of elective neck dissection in metastatic cutaneous malignancy of the parotid. Head Neck. 2013 Feb;35(2):205-208. doi: 10.1002/hed.22948.Epub 2012 Jan 31. PMID: 22290612.
  90. Brunner M, Veness M, Ch’ng S, Elliott M, Clark JR. Distant metastases from cutaneous squamous cell carcinoma – Analysis of AJCC stage IV. Head Neck. 2013 Jan;35(1):72-5. doi: 10.1002/hed.22913.Epub 2012 Jan 20. PMID: 22266877.
  91. Ch’ng S, Ashford B, Gao K, McGuinness J, Clark JR. Reconstruction of post-radical parotidectomy defects. Plast Reconstr Surg. 2012 Feb;129(2):275e-287e. doi: 10.1097/PRS.0b013e318213a11a. PMID: 21311387.
  92. Ch’ng S, Palme CE, Wong GL, Brunner M, Ashford B, McGuinness J, Clark JR. Reconstruction of the (crico)trachea for malignancy in the virgin and irradiated neck. J Plast Reconstr Aesthet Surg. 2012 Dec;65(12):1645-53. doi: 10.1016/j.bjps.2012.07.008. PMID: 22921310.
  93. Ch’ng S, Clark JR. The scapular angle adds versatility to the latissimus dorsi free flap in complicated scalp reconstruction. J Plast Reconstr Aesthet Surgery. 2011 Sep;64(9):e248-9. doi: 10.1016/j.bjps.2011.03.032. PMID: 21498137.
  94. Low I, Ch’ng S, Ng D, Brasch H, Sullivan M, Davis P, Tan ST. HER2 polysomy in aggressive head and neck cutaneous squamous cell carcinoma. Hum Pathol. 2009 Jun;40(6):902-3. doi: 10.1016/j.humpath.2008.12.012. PMID: 19269011.
  95. Ch’ng S, Tan ST. Genetics, cellular biology and tumor microenvironment of melanoma. Front Biosci (Landmark Ed). 2009 Jan 1;14(3):918-28. doi: 10.2741/3286. PMID: 19273108.
  96. Ch’ng S, Maitra A, Allison R, Chaplin J, Gregor RT, Lea R, Tan ST. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma. J Surg Oncol. 2008 Aug 1;98(2):101-5. doi: 10.1002/jso.21092. PMID: 18523982.
  97. Ch’ng S, Low I, Ng D, Brasch H, Sullivan M, Davis P, Tan ST. Epidermal growth factor receptor – A novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma. Hum Pathol. 2008 Mar;39(3):344-9. doi: 10.1016/j.humpath.2007.07.004. Epub 2007 Nov 28. PMID: 18045646.
  98. Ch’ng S, Tan ST. Facial port-wine stains: Clinical stratification and risks of neuro-ocular involvement. J Plast Reconstr Aesthet Surg. 2008 Aug;61(8):889-93. doi: 10.1016/j.bjps.2007.05.011.Epub 2007 Jul 2. PMID: 17604243.
  99. Ch’ng S, Sullivan M, Yuan L, Davis P, Tan ST. Mast cells deregulate apoptotic and cell cycle genes in mucosal squamous cell carcinoma. Cancer Cell Int. 2006 Dec 19;6:28. doi: 10.1186/1475-2867-6-28. PMID: 17177999.
  100. Ch’ng S, Maitra A, Lea R, Brasch H, Tan ST. Parotid metastasis – An independent prognostic factor in head and neck cutaneous squamous cell carcinoma. J Plast Reconstr Aesthet Surg. 2006;59(12):1288-93. doi: 10.1016/j.bjps.2006.03.043.Epub 2006 Jun 5. PMID: 17113505.
  101. Ch’ng S, Wallis R, Yuan L, Davis P, Tan ST. Mast cells and cutaneous malignancies.  Mod Pathol. 2006 Jan;19(1):149-59. doi: 10.1038/modpathol.3800474. PMID: 16258517.
  102. Ch’ng S, Hulme-Moir M. New Zealand’s early experience in stapled haemorrhoidopexy. N Z Med J. 2006 Mar 10;119(1230):U1880.PMID: 16532046.
  103. Nikitins M, Griffin P, Ch’ng S, Rice N. Dynamic anatomical study of ulnar nerve motion after anterior transposition for cubital tunnel syndrome. Hand Surg. 2002 Dec;7(2):177-82. doi: 10.1142/s0218810402001114. PMID: 12596275.

Book Chapters

  1. Morrison E, Rastogi P, Chen YR, Ch’ng S. Chapter 8: Overview of Head and Neck:  Bony and Soft Tissue Tumors. In: Losee and Hopper: Craniofacial, Head and Neck Surgery, and Pediatric Surgery, Vol. 3; Neligan: Plastic Surgery, 5th ed.
  1. Ch’ng S, Varey AHR. Chapter 30: Melanoma, Gurtner: Principles of Plastic Surgery, Vol. 1; Neligan: Plastic Surgery, 5th
  1. Ch’ng S, Yung A. Chapter 16: Helical root perforator flap. In Blondeel PN, Morris SF, Hallock GG, and Neligan PC: Perforator Flaps: Anatomy, Technique and Clinical Applications, 3rd ed.
  1. Guminski A, Ch’ng S, Cancer Council Australia Keratinocyte Cancers Guideline Working Party. Guidelines: Keratinocyte Carcinoma – metastatic disease and systemic therapies. In: Cancer Council Australia Keratinocyte Cancers Guideline Working Party. Clinical practice guidelines for keratinocyte cancer. Sydney: Cancer Council Australia. https://wiki.cancer.org.au/australia/Guidelines:Keratinocyte_carcinoma/Metastatic_disease_systemic_therapies
  1. Ch’ng S, Tan-Gore E, JF Thompson. Management of the Parotid/Neck Following a Positive Sentinel Node Biopsy in Patients with Cutaneous Melanoma of the Head and Neck. In: Difficult Decisions in Head and Neck Oncologic Surgery, July 2019. doi: 10.1007/978-3-030-15123-2_23.
  1. Ch’ng S, Shannon K. Regional lymph node metastases: Neck dissection. In: Stretch J, editor. iBook Melanoma Principles & Practice, A Comprehensive Guide. Sydney: Melanoma Institute Australia, 2016.
  1. Ch’ng S, Skoracki R. Scapular and parascapular flaps. In: Hanasono M, Yu P, editors. Reconstructive Surgery of the Head and Neck. New York: Thieme, 2016.
  1. Ch’ng S, Low I, Alexander A, Clark JR. Non-melanoma skin cancers of the head and neck. In: Gullane P, Goldstein D, editors. Sataloff’s Textbook of Otolaryngology. Philadelphia: Jaypee Medical Publishers, 2015.
  1. Ch’ng S, Low I, Alexander A, Clark JR. Other rarer non-melanoma skin cancers of the head and neck. In: Gullane P, Goldstein D, editors. Sataloff’s Textbook of Otolaryngology. Philadelphia: Jaypee Medical Publishers, 2015.
  1. Ch’ng S, Low I, Clark JR. Non-melanoma skin cancers of the head and neck. In: Kountakis SE, editor. Encyclopedia of Otolaryngology, Head and Neck Surgery. New York: Springer, 2013.
  1. Lee K, Ch’ng S, Ashford B. Sinonasal melanoma. In: Kountakis SE, editor. Encyclopedia of Otolaryngology, Head and Neck Surgery. New York: Springer, 2013.
  1. Lee K, Ch’ng S, Ashford B. Oral melanoma. In: Kountakis SE, editor. Encyclopedia of Otolaryngology, Head and Neck Surgery. New York: Springer, 2013.
  1. Lee K, Ch’ng S, Ashford B. Primary laryngeal mucosal melanoma. In: Kountakis SE, editor. Encyclopedia of Otolaryngology, Head and Neck Surgery. New York: Springer, 2013.
  1. Ch’ng S, Tan ST, Davis P, Brasch H, Sullivan M. Skin cancers and the cell cycle. In: Chen KC, editor. Progress in Cell Cycle Research. New York: Nova Science Publishers, 2008.